Published at Sep 09, 2022 by Yahoo Finance
Lophius Biosciences News on
HackerNoon and Around the Web
Lophius Biosciences is a young biotechnology company developing innovative products for the diagnosis of acute infectious and autoimmune diseases. The company is also offering ...
Articles Around the Web
GRO Biosciences Announces Addition of Nicole Paulk, PhD, to Scientific Advisory Board
Caladrius Biosciences Announces Participation in Upcoming Investor Conferences in September 2022
Published at Sep 08, 2022 by Yahoo Finance
Inherent Biosciences Raises Series A Funding
Published at Sep 08, 2022 by finsmes
Pyramid Biosciences Names Biren Amin as Chief Financial and Strategy Officer
Published at Sep 07, 2022 by PharmiWeb
Neurocrine Biosciences Looks Promising: Here's Our Trading Strategy
Published at Sep 07, 2022 by TheStreet.com
Arpeggio Biosciences rakes in $17M to measure the transcriptome
Published at Sep 07, 2022 by MedCity News
RGAIA Investment: “Cytek Biosciences (CTKB) is Profitable Today & Will be Even More So in the Future”
Published at Sep 07, 2022 by Insider Monkey
Precision BioSciences management changes mean new roles for co-founders
Published at Sep 06, 2022 by WRAL TechWire
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) On An Uptrend: Could Fundamentals Be Driving The Stock?
Published at Sep 05, 2022 by Nasdaq
Kimia Biosciences launches new logo, new website
Published at Sep 05, 2022 by India Infoline
Read More Tech Stories Related to #Lophius Biosciences
The data for this page is pulled via HackerNoon API, Bing News API, and BigPicture API. We work hard to make it near real-time but we are in beta and not giving any investment or legal advice.
Learn more about how HackerNoon works with brands like Heroku, AngelList, Kik and Indeed to publish their blog posts, press releases, data, and software updates.